Dr. Mike Israetel is shifting his focus from traditional fitness to what he calls “the enhancement revolution.” After years of teaching evidence-based training and nutrition, Israetel now sees pharma and surgical interventions as the future of human optimization.
While resistance training and proper nutrition can transform physiques, Israetel now advocates for medical interventions that deliver superior results with less effort. He is particularly enthusiastic about GLP-1 medications like semaglutide and tirzepatide, which significantly reduce appetite and accelerate fat loss. The next generation promises even greater benefits. Retatrutide, currently in trials, not only suppresses hunger but also increases metabolic rate, leading to faster body composition changes while preserving energy.
“You could just lose like four pounds (1.8 kg) of fat a week. Unbelievable, right? And it’ll be amazing and you feel great because dieting really wears you down and with retatrutide it doesn’t really do that, which is just totally mind-blowing,” – Israetel told Jack Neel.
Israetel says. He predicts these medications will soon be available in oral form, eliminating weekly injections. More significantly, he anticipates the development of non-androgenic anabolics, compounds that build muscle without the harmful effects of traditional PEDs.
“You take this pill and you lose only fat, you gain muscle, and within a year you’ve lost 30 pounds (13.6 kg) of fat, gain 10 pounds (4.5 kg) of muscle, your blood work is unbelievably better,”
he says.
This pharmaceutical approach extends to cosmetic surgery, which Israetel personally embraced. After removing persistent body composition issues through liposuction, he reports substantial satisfaction improvements.
“I look at my body and I look at my midsection and I’m just like, wow, this is really cool. I love it. My entire adult life, I can never remember I had love handles and now I don’t,”
he reflects.
Israetel acknowledges that enhancement carries risks and trade-offs. He cautions against dismissing health concerns, noting that youthful invincibility fades when facing medical consequences. Still, he believes informed adults should have access to these tools without stigma. Historically, artificial interventions carried significant downsides, creating reasonable skepticism. Modern medicine has dramatically improved risk-benefit ratios.
He views human biology as contingent rather than optimal, arguing that every characteristic could theoretically be improved, including the elimination of distress itself.
“As AI ascends us into hyper intelligence and now you know what’s good and what’s bad to do in every little part of your life, distress, the force of distress is like a little predictive few steps away from harm,”
Israetel theorizes. In his vision, advanced psychiatric meds could reduce negative emotional states tenfold.
The implications extend beyond individual choice. As these technologies become mainstream, Israetel suggests adoption will shift from optional to socially necessary.
“If you’re like the last person in 2032 to get some kind of enhancement or take some kind of pharmaceutical or whatever, everyone’s just going to be a lot better looking than you and fitter and healthier and happier.”
This democratization has already begun. Cosmetic procedures once reserved for celebrities are now commonplace among young professionals with minimal social stigma. Weight management medications have similarly moved from controversial to accepted in just a few years.
For Israetel, the enhancement revolution represents compassion rather than vanity. People living in bodies they dislike experience real distress that affects every domain of life. If science can safely alleviate that distress, restricting access based on outdated naturalism serves no ethical purpose.
“At the end of the day, it’s just about how adults want to look inside their own bodies. How do you want to look? We’re not telling you how you want to look.”
